Stereotaxis, Inc. Common Stock (STXS) is a publicly traded Healthcare sector company. As of May 21, 2026, STXS trades at $1.85 with a market cap of $173.97M and a P/E ratio of -7.65. STXS moved +6.94% today. Year to date, STXS is -21.61%; over the trailing twelve months it is -11.48%. Its 52-week range spans $1.54 to $3.59. Analyst consensus is strong buy with an average price target of $4.13. Rallies surfaces STXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own STXS include Redmile Group. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Stereotaxis, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $1.85 |
| Market Cap | $173.97M |
| P/E Ratio | -7.65 |
| EPS | $-0.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.59 |
| 52-Week Low | $1.54 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $-681.00K |
| Net Income | $-21.68M |
| Gross Margin | -2467.11% |
4 analysts cover STXS: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.13.